The use of hydrolytic enzymes as adjuvant therapy in AIDS/ARC/LAS patients. NLM AIDSLINE Important note: Information in this article was accurate in 1988. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


The use of hydrolytic enzymes as adjuvant therapy in AIDS/ARC/LAS patients.

Biomed Pharmacother. 1988;42(1):31-4. Unique Identifier : AIDSLINE MED/88309909
Stauder G; Ransberger K; Streichhan P; Van Schaik W; Pollinger W; Medizinische Enzymforschungsgesellschaft, Geretsried, FRG.

Abstract: The purpose of this paper is to discuss a hypothesis corroborating the use of hydrolytic enzymes in AIDS/ARC/LAS patients, showing high levels of circulating immune complexes (CIC). Other diseases, revealing high CIC-levels as well, may be improved or even cured by eliminating CIC. The results obtained from experiences of CIC-elimination by hydrolytic enzymes are presented below. As may be determined from the data available, hydrolytic enzymes should be included in the therapy of HIV-positive patients. Clinical trials are being continued.
Keywords: Acquired Immunodeficiency Syndrome/*DRUG THERAPY/IMMUNOLOGY *Antigen-Antibody Complex AIDS-Related Complex/*DRUG THERAPY/IMMUNOLOGY Comparative Study Human Hydrolases/*THERAPEUTIC USE Immunosuppressive Agents/THERAPEUTIC USE Phagocytosis Plasmapheresis JOURNAL ARTICLE

KWDacquiredimmunodeficiencysyndrome/KWDdrugtherapy/immunologyKWDantigen-antibodycomplexaids-relatedcomplex/KWDdrugtherapy/immunologycomparativestudyhumanhydrolases/KWDtherapeuticuseimmunosuppressiveagents/therapeuticusephagocytosisplasmapheresisjournalarticle
881230
M88C0599

Copyright © 1988 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1988. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1988. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .